Introduction
============

Despite the array of different proteins and peptides with distinct amino acid sequences that are known to be able to assemble into amyloid fibrils *in vitro* and/or *in vivo* ([@B1]), the precise molecular mechanism(s) by which these different proteins/peptides self-assemble into amyloid fibrils and how the assembly process results in disease remain unclear ([@B2]). Amyloid formation commences with the generation of aggregation-prone monomeric precursors. These species can be unfolded/disordered, partially structured or even native-like ([@B3]) and their structural properties, even though potentially similar to their non-amyloidogenic counterparts, dictate the fate of amyloid assembly ([@B4]). This is exemplified by the observation that the same amino acid sequence can form conformationally distinct amyloid structures *in vitro* by varying the temperature, altering the agitation conditions, adding co-solvents, metal ions or other molecules, or even changing the surface properties of the incubation vessel (reviewed in Ref. [@B5]). An extra level of complexity is added by the ability of different protein/peptide precursors to co-polymerize, resulting in new fibril polymorphs with different amyloid architectures, stabilities, and/or different kinetics of assembly than those formed by each protein alone ([@B4], [@B6], [@B7]). Indeed, there are multiple examples of amyloidogenic proteins that are able to co-polymerize such as islet amyloid polypeptide and Aβ ([@B6], [@B8]), Tau and α-synuclein ([@B9]), and insulin and transthyretin ([@B10]). Although the importance of identifying and characterizing rarely populated amyloidogenic precursors is widely appreciated ([@B3]), this remains a significant challenge because of the transient nature and heterogeneity of assembly intermediates ([@B11]). The development of reagents able to discriminate aggregation-prone species among a pool of structurally similar molecules is crucial to deciphering the mechanisms of protein assembly into amyloid and to inform the design of therapeutic/diagnostic strategies able to target individual amyloid precursors ([@B12]).

Human β~2~-microglobulin (hβ~2~m)[^5^](#FN4){ref-type="fn"} is a small protein that forms amyloid deposits in collagen-rich osteoarticular sites, resulting in the disorder dialysis-related amyloidosis (DRA) ([@B13], [@B14]). Despite the propensity of hβ~2~m to form amyloid fibrils *in vivo*, conditions that destabilize the native structure of hβ~2~m such as low pH ([@B15]), the presence of SDS ([@B16]), or other co-solvents or metal ions ([@B17], [@B18]), are required for fibril formation on an experimentally tractable time scale *in vitro*. Removal of the N-terminal six residues from hβ~2~m (the sequence IQRTPK), creating the variant ΔΝ6, disrupts the thermodynamic and kinetic stability of hβ~2~m and, as a result, ΔN6 can self-assemble into amyloid fibrils rapidly and spontaneously without the need to add detergents, metal ions, or other reagents ([@B19], [@B20]). ΔN6 retains a native-like structure, displaying a backbone r.m.s.d. of only ∼1.5 Å compared with hβ~2~m ([@B19]), and contains a non-native *trans* X-Pro-32 (see [Fig. 1](#F1){ref-type="fig"}, *A* and *B*), which has been shown to be vital for fibril formation ([@B21], [@B22]). Isomerization of the X-Pro-32 bond results in structural reorganization of the side chains in the apical region of hβ~2~m, resulting in a protein with different surface hydrophobicity and electrostatic properties ([@B19]). ΔN6 can also promote the aggregation of hβ~2~m even when added in trace amounts ([@B19]), resulting in co-polymerization of both proteins into hetero-polymeric amyloid fibrils ([@B4]). This interaction allows amyloid formation of hβ~2~m to be investigated in the absence of additives at physiologically relevant pH values ([@B4]).

The design of molecules able to bind hβ~2~m or its amyloidogenic counterpart, ΔN6, would offer an opportunity to increase understanding of the interaction between these co-assembling monomers and explore the aggregation pathway that leads to their co-polymerization into amyloid fibrils. However, such a task is hindered by the high sequence and structural homology (see [Fig. 1](#F1){ref-type="fig"}*A*) of the two proteins and their dynamic nature ([@B19]). In this study, we used *in vitro* selection to identify an RNA aptamer able to bind hβ~2~m preferentially to ΔN6 and to alter fibril co-assembly. Nucleic acid aptamer selection has been used previously to generate RNA aptamers able to discriminate monomeric PrP^SC^ and recombinant PrP^C^ ([@B23], [@B24]) and to bind to Aβ monomers rather than fibrils ([@B25][@B26][@B27]). Oligomers of amyloidogenic proteins have also been used as targets: DNA/RNA aptamers have been raised against oligomers of α-synuclein ([@B28]) and Αβ40 ([@B29]), respectively.

Previously, we used SELEX to isolate RNA aptamers against fibrillar hβ~2~m that were counter-selected against the low pH, partially unfolded, hβ~2~m monomer from which these fibrils were formed ([@B30]). Here, we extend this approach using SELEX to isolate 2′fluoro-modified RNA aptamers against native monomeric hβ~2~m. The selected aptamer discriminates in its binding to hβ~2~m or ΔN6 at pH 6.2, conditions in which both proteins are folded, but only ΔN6 is able to assemble spontaneously into amyloid fibrils ([@B19]). The hβ~2~m specific aptamer was minimized to a 44-nucleotide-long fragment and its binding interface, affinity, and specificity for hβ~2~m were determined. The aptamer binds tightly and specifically to the β-sheet of hβ~2~m containing the A, B, E, and D β-strands, but only weakly and less specifically to ΔN6. Addition of the aptamer to a mixture of hβ~2~m and ΔN6 under conditions (pH 6.2) that promote co-assembly ([@B4]) disfavors the interaction between the two proteins early in assembly, making hβ~2~m remain soluble for longer. The results reveal the ability of RNA aptamers to discriminate and bind to a specific protein conformer within a complex mixture of structurally similar co-polymerizing species, altering the course of amyloid assembly.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Protein Preparation

hβ~2~m and ΔN6 were expressed and purified as described previously ([@B19]). For NMR experiments, ^15^N- and ^13^C-labeled hβ~2~m and ΔN6 were prepared as described in Ref. [@B31].

#### Biotinylation and Immobilization of hβ~2~m

Monomeric hβ~2~m (∼1 mg) was biotinylated (EZLink^TM^ Sulfo-NHS-LC-LC-biotin, Pierce Biotechnologies) at pH 7 using a 20-fold molar excess of biotin over the total protein concentration, according to the manufacturer\'s instructions. The biotinylated monomer was then immobilized on 1-μm streptavidin-coated microspheres (Dynabeads^TM^, Invitrogen) using the manufacturer\'s instructions.

#### In Vitro Selection

A Biomek 2000 laboratory automation work station (Beckman Coulter) was used to perform 12 rounds of *in vitro* selections with an N30 library of 2′F-modified pyrimidine RNA, encompassing ∼10^15^ potential sequences, and transcribed using the Y639F/H784A variant of T7 RNA polymerase ([@B32]), using minor modifications of the protocols described previously ([@B30]). Selections were carried out in 50 m[m]{.smallcaps} MES buffer containing 120 m[m]{.smallcaps} NaCl, pH 6.2. Negative selections were carried out at each round of SELEX using streptavidin Dynabeads coated with Tris-inactivated linker. Stringency was increased after round 5 by decreasing the number of beads containing monomeric hβ~2~m by half and increasing the number of washes from 10 to 13. The reverse transcriptase-PCR products were analyzed by native PAGE after each group of five rounds of selection to confirm the isolation of products for the next round of selection. Individual aptamer clones were produced by *in vitro* transcription using 10 m[m]{.smallcaps} final concentrations of each nucleotide triphosphate using 2′F-CTP and 2′F-UTP for production of modified RNAs. RNA concentrations were determined using the following extinction coefficients: B6, 1026.3 m[m]{.smallcaps}^−1^ cm^−1^; B6 minimized (B6min), 553.2 m[m]{.smallcaps}^−1^ cm^−1^; B9, 1054.2 m[m]{.smallcaps}^−1^ cm^−1^.

#### Synthesis of Minimized B6

B6min (5′-GGG AAU UCU GAG CUA CUC CCU UUU GGG CCC GGC UAU GAU UCC CG-3′) was synthesized with and without 2′F-modified pyrimidine nucleotides (named 2′F B6min and 2′OH B6min, respectively) on an ABI 394 RNA synthesizer at a 1 μ[m]{.smallcaps} scale using the protocols described previously ([@B33]). The phosphoramidites used for synthesis of 2′F-B6min were as follows: *N*-benzoyl-protected adenosine, *N*-dimethylformamidinyl-protected guanosine, *N*-acetyl-protected-2′-fluoro deoxycytidine, and 2′-fluoro-deoxyuridine. For synthesis of 2′-OH B6min *N*-acetyl-protected-2′-fluoro-deoxycytidine and 2′-fluoro-deoxyuridine were replaced with *N*-acetyl-protected-cytidine and uridine phosphoramidites (Link Technologies, Ltd.). Cyanoethyl-(*N*,*N*′-diisopropyl) and *t*-butyldimethylsilyl groups were present on the 3′- and 2′-hydroxyl groups. Treatment with ammonia-saturated methanol at room temperature for 24 h was used to remove protecting groups and to cleave RNA from controlled pore glass resin. Methanol was removed under vacuum and the RNA pellet re-suspended in anhydrous dimethyl sulfoxide. One volume of triethylamine trihydrofluoride was added and incubated at room temperature to remove *t*-butyldimethylsilyl, the deprotected RNA was precipitated with butan-1-ol and resuspended in diethylpyrocarbonate-treated water (Severn Biotech) before being purified by reverse-phase HPLC at 55 °C ([@B34]). RNA fractions were collected, lyophilized, and desalted into 18.2 megohm H~2~O. The RNA was analyzed on a 10% (w/v) denaturing polyacrylamide urea gel stained with ethidium bromide. The RNA was synthesized using *N*-dimethylformamidinyl-protected guanosine controlled pore glass to avoid incorporation of a pyrimidine with a ribose sugar at the 3′-end. This additional guanosine has no effect on the secondary structure of 2′F-B6min or 2′-OH B6min as predicted by Mfold ([@B35]).

#### Surface Plasmon Resonance

A BIAcore3000 instrument was used with a streptavidin-coated gold sensorchip (BIAcore SA chip). A flow-rate of 10 μl min^−1^ was used with a running buffer of 50 m[m]{.smallcaps} MES, 120 m[m]{.smallcaps} NaCl, pH 6.2. 50 μl of 50 μg ml^−1^ of biotinylated monomer was injected over separate flow cells so that ∼200 response units of protein was immobilized. RNAs were dialyzed into running buffer before injection across the surface to minimize bulk refractive index effects. Flow cells were regenerated using a 20-μl wash of 5 [m]{.smallcaps} NaCl. All sensorgrams were corrected by subtracting the signals of an equivalent injection across an underivatized flow cell. Data were analyzed using the manufacturer\'s software (BIAevaluation).

#### Intrinsic Fluorescence Quenching

The fluorescence of tryptophan residues in 1 μ[m]{.smallcaps} hβ~2~m or ΔN6 was excited at 290 nm, and fluorescence emission was measured between 300 and 390 nm in the presence of increasing concentrations of 2′F B6min or 2′OH B6min in 50 m[m]{.smallcaps} MES buffer containing 120 m[m]{.smallcaps} NaCl, pH 6.2, at 25 °C. Due to the large extinction coefficient of the RNA aptamer at 260 nm (553.2 m[m]{.smallcaps}^−1^ cm^−1^), the absorbance of the hβ~2~m/aptamer solution at 290 nm was measured after each addition of aptamer to ensure that the absorbance of the solution was below 0.05 at 290 nm so that inner filter effects do not contribute to the data ([@B36]). Fluorescence emission was measured using a Photon Technology International QM-1 spectrofluorimeter using 10-nm slit-widths. The data for binding of 2′F B6min to hβ~2~m were normalized to a value of 0 in the absence of aptamer and a fluorescence signal of 1 obtained upon saturation. The data were then fitted to the following logistic equation to extract the half maximal effective concentration (EC~50~) using in-house scripts, where max and min represent the maximum and minimum fluorescence signals, respectively, Hill is the Hill coefficient, *f*(*x*) is the fluorescence units, and *x* is the concentration of the aptamer in n[m]{.smallcaps}. For 2′F B6min to ΔΝ6 and 2′OH B6min to hβ~2~m, no change in fluorescence was observed over the concentration range studied.

#### NMR Spectroscopy

Samples of ^13^C-^15^N-labeled protein (60 μ[m]{.smallcaps}) in 50 m[m]{.smallcaps} MES buffer containing 120 m[m]{.smallcaps} NaCl, pH 6.2, 0.02% (w/v) sodium azide, 0.1 m[m]{.smallcaps} EDTA, 90% (v/v) H~2~O/10% (v/v) D~2~O were used for NMR experiments. Synthetic 2′F B6min or 2′OH B6min was added into the protein solution from a concentrated stock (typically 200 μ[m]{.smallcaps}). Working at a concentration of 60 μ[m]{.smallcaps} necessitated the use of a sensitivity optimized strategy for obtaining assignments. This was achieved using a reduced dimensionality approach based on Hadamard encoding ([@B37]). Sequential assignments were obtained from analysis of Hadamard encoded two-dimensional H(N-H~2~)CA and H(N-H~2~)(CO)CA experiments where a two-step Hadamard matrix is introduced on ^15^N to subdivide the peaks into two subspectra where most signals can be addressed from their ^1^H shift alone and the dimensionality can be reduced to 2 to maximize sensitivity. Spectra were recorded at 25 °C on a Varian Inova 750 MHz spectrometer equipped with a cryogenic probe and were processed using NMRPipe and analyzed using Collaborative Computational Project for NMR analysis ([@B38]). To calculate the intensity profiles shown in [Fig. 7](#F7){ref-type="fig"}, peak intensities were normalized to the number of scans and the protein concentration used for each experiment. Intensity profiles were calculated as the ratio of the normalized peak intensity of each resonance in the apo spectrum (*I*~0~) *versus* the normalized intensity at the same position but in the aptamer-bound spectrum (*I*). Therefore, the loss of native signal plotted in [Fig. 7](#F7){ref-type="fig"} does not require full assignment of the aptamer-bound spectrum.

#### Assembly of Amyloid Fibrils

40 μ[m]{.smallcaps} hβ~2~m and 40 μ[m]{.smallcaps} ΔN6 in the presence or absence of two molar equivalents of 2′F B6min were co-incubated in 50 m[m]{.smallcaps} MES buffer containing 120 m[m]{.smallcaps} NaCl, pH 6.2, 0.02% (w/w) sodium azide at 600 rpm, 37 °C in a Thriller Thermoshaker incubator (Peqlab). Each sample (100 μl) was incubated in 0.5-ml plastic Eppendorf tubes. Aliquots of 8 μl were removed at different time points during incubation and immediately centrifuged at 14,000 × *g* for 20 min. The supernatant was separated from the pellet, and both supernatant and pellet were frozen at −20 °C for subsequent analysis by SDS-PAGE.

#### SDS-PAGE

The effect of 2′F B6min on fibril formation was monitored using 15% polyacrylamide Tris-Tricine gels. Samples of the supernatant and pellet were thawed, and the pellet was resuspended in 8 μl of 50 m[m]{.smallcaps} MES buffer containing 120 m[m]{.smallcaps} NaCl, pH 6.2. Both the supernatant and resuspended pellet were added 1:1 to loading buffer (50 m[m]{.smallcaps} Tris-HCl, pH 6.8, 100 m[m]{.smallcaps} DTT, 2% (w/v) SDS, 0.1% (w/v) bromphenol blue, and 10% (v/v) glycerol) and boiled for 5 min before loading 15 μl into the gel. Gels were stained with Coomassie Instant Blue (Expedeon) and imaged by SnapGene software (Syngene).

#### Electron Microscopy

At the end of fibril assembly, 10 μl of sample were applied to a carbon-coated grid. The grid was then carefully dried with filter paper before it was negatively stained by the addition of 10 μl of 4% (w/v) uranyl acetate as described in Ref. [@B39]. Micrographs were recorded on a Philips CM10 or a JEOL JEM-1400 electron microscope.

RESULTS
=======

### 

#### Selection of hβ~2~m-specific 2′F-RNA Aptamers

Co-incubation of ΔN6 and hβ~2~m results in the two proteins polymerizing into hetero-polymeric amyloid-like fibrils that are morphologically and thermodynamically distinct compared with fibrils formed by ΔN6 or hβ~2~m alone ([@B4]). To control the co-assembly of these proteins, we attempted to select RNA aptamers capable of discriminating between natively folded hβ~2~m and ΔN6 at pH 6.2 ([Fig. 1](#F1){ref-type="fig"}*A*). Hβ~2~m was biotinylated (predominantly at the N terminus and on Lys-7 and/or Lys-92) and immobilized as a target on streptavidin-coated magnetic beads, as described previously ([@B30]). The initial SELEX protocol used an N30 2′F-pyrimidine substituted RNA library to create aptamers resistant to nucleases ([@B25], [@B32]) and included counter-selection against ΔN6 monomers immobilized as for hβ~2~m, as well as long straight and worm-like amyloid fibrils formed from hβ~2~m at acidic pH ([@B40]). This protocol resulted in the removal of most of the aptamers from the selected pool, consistent with the different protein conformers containing many epitopes in common. We therefore abandoned counter-selections, except against biotin linker-blocked streptavidin beads alone. In addition, in the final round of SELEX, aptamers bound to bead-immobilized hβ~2~m were competed off the beads using non-biotinylated hβ~2~m in solution to ensure that the selected aptamer pool contained ligands for native epitopes, SELEX was carried out at pH 6.2 as this is both optimal for hβ~2~m/ΔN6 co-polymerization (hβ~2~m does not self-assemble spontaneously on a relevant time scale at this pH, whereas ΔN6 assembles rapidly) ([@B4]) and is physiologically relevant for amyloid deposition in patients with DRA ([@B41], [@B42]). In total, 12 SELEX rounds were performed, with rounds 6--12 having increased stringency (see "Experimental Procedures"). From the final pool, 11 RNA clones were sequenced and aligned using the program AliBee ([@B43]). These were then clustered using the phylogenetic software Clustal Omega ([Fig. 2](#F2){ref-type="fig"}*A*) ([@B44]).

![**Comparison of the structures of hβ~2~m and ΔΝ6.** *A*, the structure of hβ~2~m (*gray ribbon*, Protein Data bank code [2XKS](2XKS) ([@B19])) and ΔN6 (*red* schematic, Protein Data Bank code [2XKU](2XKU) ([@B19])). The two β-sheets of the proteins comprising the A, B, E, and D β-strands and the C, F, and G β-strands are shown. Pro-32 is shown in space fill. *B*, per residue r.m.s.d. chart for the backbone atoms of hβ~2~m and ΔΝ6 (overall backbone r.m.s.d. ∼ 1.5Å). The positions of the β-strands in these proteins are shown on *top* as *gray* (hβ~2~m) and *red* (ΔΝ6) ribbons.](zbc0421496570001){#F1}

![**Aptamer selection.** *A*, the relationship of B6 to the 10 other sequences from the SELEX pool. *B*, sequences of aptamers B6 and B9. The selected regions are shown in *red*, and their common sequence motifs are *underlined. C*, surface plasmon resonance traces generated upon incubation of 1 μ[m]{.smallcaps} 2′F B6 (50 m[m]{.smallcaps} MES buffer, 120 m[m]{.smallcaps} NaCl, pH 6.2) over flow cells immobilized with hβ~2~m (*red*), ΔN6 (*dark green*), or murine β~2~m (*light green*). *RU*, response units.](zbc0421496570002){#F2}

#### Isolation of 2′F B6 and Characterization of the Binding Affinity to hβ~2~m

Two aptamers, B6 and B9, contained the most frequently occurring sequence motifs within the sequenced clones and showed some motif similarities ([Fig. 2](#F2){ref-type="fig"}, *A* and *B*). To identify which aptamer to utilize for further studies, an initial binding assay was employed using surface plasmon resonance. Biotinylated hβ~2~m, ΔN6, or the non-amyloidogenic murine β~2~m ([@B45]) were immobilized on separate flow cells and aptamer binding monitored at pH 6.2. 2′F B6 binds to hβ~2~m with an apparent affinity of ∼500 n[m]{.smallcaps} (*red trace* in [Fig. 2](#F2){ref-type="fig"}*C*), but did not bind ΔN6 (*dark green trace*) or murine β~2~m (*light green trace*). In contrast, binding of 2′F B9 was so weak that the *K~d~* could not be determined (data not shown). The secondary structure of B6, computed via Mfold to be a stable stem loop (ΔG° ∼ −16 kcal/mol) ([Fig. 3](#F3){ref-type="fig"}*A*) ([@B35]), was confirmed using enzymatic solution structure probing ([Fig. 3](#F3){ref-type="fig"}*B*). This analysis suggests that the selected region consists of an extended base-paired stem loop interrupted by several single-stranded bulges with a terminal loop consisting of a poly-U tetraloop (highlighted in *red* in [Figs. 2](#F2){ref-type="fig"}*B* and [3](#F3){ref-type="fig"}*A*). Note that both Mfold and enzymatic probing were of transcripts containing natural pyrimidines. B9 is predicted to have several equivalently stable structures that are all identical in the selected region, which forms a structure very similar to that of B6 around one of the bulges ([Fig. 3](#F3){ref-type="fig"}*C*). B9 differs radically at the terminal loop, however, which is composed of six purine nucleotides. It appears that the loop is the motif that provides much of the binding energy for the interaction of B6 with hβ~2~m. Further characterization was therefore restricted to B6 and its derivatives.

![**Secondary structures of the B6 and B9 aptamers.** *A*, the Mfold secondary structure prediction of the full-length B6 aptamer with the nucleotides within the *green box* showing the region truncated to create the B6min aptamer sequence. Nucleotides *circled* in *red* define the random region. *B*, enzymatic solution structure probing of the full-length B6 transcript with the random region highlighted in *red*. Cleavage sites by the G-specific RNase T1 (*green arrows*), U and C-specific RNase A (*blue arrows*), and single-stranded RNA specific S1 nuclease (*purple arrows*) are shown. *C*, the Mfold of the full-length B9 aptamer with the selected region highlighted as described in *A*. The *dotted red boxes* in *A* and *C* showed the conserved sequences and secondary structure elements of both aptamers. *D*, secondary structure of 2′ OH B6min. *E*, 2′F B6min stem loops. These have additional 5′-GGG and 3′-CCCG sequences added to increase their folded stability. 2′F pyrimidines are circled in *green* in *E*.](zbc0421496570003){#F3}

A truncated 44-nucleotide version of the 110-nucleotide full-length B6 was produced encompassing nucleotides 22 to 59 with 2′OH (termed 2′OH B6min) ([Fig. 3](#F3){ref-type="fig"}*D*) or 2′F pyrimidines (termed 2′F B6min) ([Fig. 3](#F3){ref-type="fig"}*E*), *i.e.* all of the selected region defining the stem loop with some stabilizing additional base pairs. We examined the solution binding of 2′F B6min to native hβ~2~m and ΔN6 using fluorescence spectroscopy. hβ~2~m has two tryptophan residues: Trp-60, which lies in the DE loop ([Fig. 1](#F1){ref-type="fig"}*A*) and is solvent exposed, and Trp-95, which lies toward the C terminus of the 100-residue protein and is buried. Tryptophan fluorescence of hβ~2~m can be used to probe changes in conformation or chemical environment upon aptamer binding, with Trp-95 reporting on alterations within the hydrophobic core ([@B46]), whereas Trp-60 is sensitive to ligand binding (at least in proximity to this residue) at the protein surface. The fluorescence emission spectrum of monomeric hβ~2~m (1 μ[m]{.smallcaps}) was monitored upon titration with 2′F B6min. The results showed a decrease in tryptophan emission intensity (with little change in λ~max~), consistent with binding of 2′F B6min to the protein surface adjacent to Trp-60. Fitting the normalized intensity of Trp fluorescence *versus* the concentration of 2′F B6min added ([Fig. 4](#F4){ref-type="fig"}*A*) (see "Experimental Procedures") yielded a Hill slope of 0.99 ± 0.06, suggesting a specific one-site binding event, with an EC~50~ of 223 ± 10 n[m]{.smallcaps}. Similar assays using 2′OH B6min showed no binding to hβ~2~m ([Fig. 4](#F4){ref-type="fig"}*B*), indicating that the 2′F modifications to the pyrimidines are required for tight binding, consistent with the contribution of the polyU tetraloop to affinity. The fluorescence assay also showed no binding of 2′F B6min to ΔN6 monomers ([Fig. 4](#F4){ref-type="fig"}*C*), consistent with the surface plasmon resonance data with full-length aptamers. These results indicate, therefore, that 2′F B6min is capable of discriminating between hβ~2~m and ΔN6. 2′-Fluoro-ribose is known to prefer different sugar pucker conformations compared with unmodified residues (O4′-*endo versus* C3′-*endo*, respectively ([@B47])). This could alter the conformation of the tetraloop and hence its interaction with the protein.

![**Binding of 2′OH B6min and 2′F B6min to hβ~2~m and** Δ**N6 measured using intrinsic tryptophan fluorescence.** *A*, normalized tryptophan fluorescence of hβ~2~m (1 μ[m]{.smallcaps}) upon addition of 2′F B6min (0--1.7 μ[m]{.smallcaps}). The data are fitted to a logistic equation (*solid line*). The data are normalized (*Norm.*) between 0 (no aptamer) and 1 (the fluorescence signal in the presence of 1.7 μ[m]{.smallcaps} aptamer) (see "Experimental Procedures"). *B*, titration of hβ~2~m (1 μ[m]{.smallcaps}) with 2′OH B6min. *C*, titration of ΔN6 (1 μ[m]{.smallcaps}) with 2′F B6min. No fluorescence change was observed over the concentrations of aptamer added in *B* and *C*. These data were normalized between 0 (no aptamer) and 1 (the fluorescence signal when 1.7 μΜ of 2′F B6min was added to hβ~2~m. All experiments were performed in 50 m[m]{.smallcaps} MES buffer, 120 m[m]{.smallcaps} NaCl, pH 6.2. *AFU*, arbitrary fluoresence units.](zbc0421496570004){#F4}

#### Determining the Binding Interface of B6min with Natively Folded hβ~2~m Using NMR

To determine whether binding of 2′F B6 to hβ~2~m induces conformational changes in the protein and to map the binding site in residue-specific detail, 2′F B6min was titrated into ^15^N,^13^C-labeled hβ~2~m at 0, 0.25, 0.5, 1.0, and 2.0 molar equivalents at pH 6.2, and ^1^H-^15^N HSQC spectra were recorded. The ^1^H-^15^N HSQC spectrum of the 2:1 mixture of 2′F B6min and hβ~2~m is shown in [Fig. 5](#F5){ref-type="fig"}, *A* and *B*. Addition of 2′F B6min results in the appearance of new peaks in the spectrum and the loss of resonances assigned to native apo-hβ~2~m, indicating that the complex is in slow exchange with the apoprotein, as expected for a high affinity complex. The chemical shift changes involve some, but not all, resonances, indicative of binding of the aptamer to a specific surface. The ^1^H-^15^N HSQC spectrum of the hβ~2~m-2′F B6min complex was assigned using a combination of two-dimensional and three-dimensional NMR techniques (see "Experimental Procedures") ([Fig. 6](#F6){ref-type="fig"}*A*). The low sample concentration (60 μ[m]{.smallcaps}) and relatively large size of the complex (25.6 kDa) made assignment challenging. Of the 88 main chain resonances in the ^1^H-^15^N HSQC spectrum of hβ~2~m, 55 were successfully assigned. The assigned spectrum of the 2′F B6min-hβ~2~m complex was then used to map the binding site for 2′F B6min on the surface of the protein. Residues with the largest chemical shift differences upon aptamer binding are located on the face of hβ~2~m that contains the A, B, E, and D β-strands ([Fig. 6](#F6){ref-type="fig"}, *B* and *C*). A significant number of residues in this region could not be assigned unambiguously in the spectrum of the complex, suggesting that they experience large chemical shift differences upon aptamer binding or are not detected due to exchange line broadening ([Fig. 6](#F6){ref-type="fig"}, *B* and *C*). The titration was also performed using 2′OH B6min ([Fig. 5](#F5){ref-type="fig"}, *C* and *D*). No changes in the chemical shifts of hβ~2~m were observed, even at the 2:1 aptamer/hβ~2~m molar ratio, confirming that the presence of 2′F-modified pyrimidines is vital for high affinity binding. To investigate whether 2′F B6min is able to recognize ΔΝ6, 2 molar equivalents of the aptamer were added to 60 μ[m]{.smallcaps} ^15^N-labeled ΔΝ6, and binding was again assessed by monitoring changes in chemical shifts ([Fig. 5](#F5){ref-type="fig"}, *E* and *F*). In this sample, the large changes in chemical shifts observed previously in the hβ~2~m-2′F B6min complex ([Fig. 5](#F5){ref-type="fig"}, *A* and *B*) were not detected (*e.g.* compare residues Lys-41 and Ala-79 in [Fig. 5](#F5){ref-type="fig"}, *B* and *F*). For some resonances, small changes in chemical shift were observed; however, in those cases, the chemical shifts did not saturate, even in the presence of a 2-fold molar excess of 2′F B6 (*e.g.* residues Ser-20 and Cys-80 ([Fig. 5](#F5){ref-type="fig"}*F*)). The results thus confirm a significantly lower affinity of this aptamer for ΔN6.

![**Chemical shift changes upon the addition of aptamers to hβ~2~m and ΔN6.** *A*, the ^1^H-^15^N HSQC spectrum of ^15^N,^13^C-labeled hβ~2~m (60 μ[m]{.smallcaps}) alone (*gray*) or in the presence of two molar equivalents of 2′F B6min (*magenta*). *B*, expansion of the region *boxed* in *A. C*, the ^1^H-^15^N HSQC spectrum of ^15^N,^13^C-labeled hβ~2~m (60 μ[m]{.smallcaps}) alone (*gray*) or in the presence of two molar equivalents of 2′OH B6min (*orange*). *D*, expansion of the region *boxed* in *C. E*, the ^1^H-^15^N HSQC spectrum of ^15^N,^13^C-labeled ΔN6 (60 μ[m]{.smallcaps}) alone (*red*) or in the presence of two molar equivalents of 2′F B6min (*green*). *F*, expansion of the region *boxed* in *E*. Chemical shift changes in *B*, *D*, and *F* are annotated with *arrows*. All spectra were obtained at 25 °C, pH 6.2.](zbc0421496570005){#F5}

![**Chemical shift changes upon binding of 2′F B6min to hβ~2~m.** *A*, zoomed in regions of the two-dimensional HNCA spectrum of ^13^C,^15^N-hβ~2~m with 2 molar equivalents of 2′F B6min. The assignment walk on the Cα values is shown for the four residues. *B*, chemical shift changes of hβ~2~m upon interaction with 2′F B6min. Total chemical shift change was calculated as √((5 × Δδ ^1^H)^2^ + (Δδ ^15^N)^2^). Residues for which assignments were not possible as a consequence of exchange broadening or large chemical shift perturbation are given an arbitrary value of 5 ppm and are shown in *red*. The *dashed line* represents two S.D. over the entire data set. *C*, the structure of hβ~2~m colored according to the measured chemical shift changes shown in *B*.](zbc0421496570006){#F6}

To obtain more detailed information about the position of the 2′F B6min binding site on the surface of hβ~2~m, the intensity of each resonance was determined in the presence of a 2-fold molar excess of aptamer and compared with the intensity of its apo counterpart. The results of this analysis are shown in [Fig. 7](#F7){ref-type="fig"}*A*. Resonances arising from residues in the A, B, E, and D β-strands, the AB and DE loops, residues 3--6 in the N-terminal region, and the C-terminal 6 residues (*red* in [Fig. 7](#F7){ref-type="fig"}*A*) lose \>80% of their intensity in the spectrum of the complex. These residues form a contiguous surface on hβ~2~m ([Fig. 7](#F7){ref-type="fig"}*A*) and include the N-terminal 6 residues of hβ~2~m that are lacking in ΔN6 and confer increased affinity, consistent with these residues forming part of the interface between the RNA and the protein. Consistent with this, there is little or no change in intensity for residues that lie in the CC′ loop and F and G β-strands on the opposite face of hβ~2~m (*gray* in [Fig. 7](#F7){ref-type="fig"}*A*). By contrast with these results, addition of a 2-fold molar excess of 2′OH B6min to hβ~2~m has no significant effect on the intensities of the resonances of native hβ~2~m ([Fig. 7](#F7){ref-type="fig"}*B*), consistent with its lack of binding.

![**2′F B6 distinguishes between two highly similar proteins.** *A*, plot of the loss of signal intensity of resonances in native hβ~2~m upon binding to a 2-fold molar excess of 2′F B6min using data shown in [Fig. 5](#F5){ref-type="fig"}*A*. Profiles were calculated as the ratio of the peak intensity in the presence (*I*) or absence (*I*^o^) of a 2-fold molar excess of aptamer. Intensity profiles were normalized to residues 40--45 that are not involved in the interface. Residues with a ratio of \<0.2 are colored *red*, those showing a ratio between 0.2 and 0.4 are colored *yellow*, and those with no significant decrease in intensity are colored *gray*. The structure of hβ~2~m drawn as a surface representation is shown on the *right* color-coded using the same scale. Residues with no assignments (*na*) are shown in *blue. B*, as described in *A*, but for the interaction of 2′OH B6min and hβ~2~m. *C*, as described in *A*, but for the interaction of 2′F Β6min with ΔΝ6. The secondary structure elements of the proteins are shown as ribbons on *top* of the panels.](zbc0421496570007){#F7}

A similar analysis was performed to assess the possible interaction between 2′F B6min and ΔΝ6. As expected based on the fluorescence titration results shown in [Fig. 4](#F4){ref-type="fig"}*C*, little change in intensity was observed for the vast majority of residues in this sample (compare [Fig. 7](#F7){ref-type="fig"}, *A* and *C*), consistent with weak binding to ΔN6. Furthermore, the residues that do show a difference in resonance intensity differ from those involved in the 2′F B6min-hβ~2~m interface. For example, although resonances belonging to residues in the AB loop, the E strand, and the C-terminal 6 residues of native hβ~2~m diminish in intensity by \>80% upon interaction with 2′F B6min, these resonances are largely unaffected (retaining \>60% average intensity) when ΔΝ6 is incubated with the aptamer. Moreover, the residues in ΔN6 showing the largest decrease in intensity upon addition of 2′F B6min (*red* in [Fig. 7](#F7){ref-type="fig"}*C*) are spread throughout the structure of the protein, suggesting that binding of 2′F B6min to ΔΝ6 is less specific than the 2′F B6-hβ~2~m interaction. These differences in binding presumably explain the insensitivity of tryptophan fluorescence observed upon addition of 2′F B6min to ΔΝ6.

The 2′F B6min-hβ~2~m interface defined by these experiments ([Fig. 8](#F8){ref-type="fig"}, *A--C*) includes a large number of aromatic side chains (Tyr-10, Phe-22, Tyr-26, Phe-56, Tyr-63, Tyr-66, and Tyr-67, *green* in [Fig. 8](#F8){ref-type="fig"}*C*), as often found in protein-RNA complexes ([@B48]). The residues involved in the binding interface might also be expected to be positively charged, but there appears to be an equal balance of positively charged residues (Arg-3, Lys-6, His-13, Lys-19, Lys-48, His-51, and Lys-94 (*blue* in [Fig. 8](#F8){ref-type="fig"}*C*)) and negatively charged side chains (Glu-16, Asp-38, Glu-50, Asp-53, Asp-59, Glu-69, and Asp-98 (*pink* in [Fig. 8](#F8){ref-type="fig"}*C*)). Analysis of the NMR data shows that residues 3--6 are clearly part of the binding site. This sequence is absent in ΔΝ6, which binds very poorly, and contains two positive charges (Arg-3 and Lys-6), but no negative charges. This region is therefore a candidate for a favorable electrostatic interaction with the aptamer. Indeed, murine β~2~m, which does not bind this aptamer ([Fig. 2](#F2){ref-type="fig"}*C*), has a Gln substituted for Lys at residue 6 (N-terminal sequence of murine β~2~m is IQKTPQ), implying that Lys-6 is a likely key recognition element for hβ~2~m.

![**Mapping the 2′F B6min-hβ~2~m binding site.** *A*, the residues in hβ~2~m that show the largest decrease in intensity upon interaction with 2′F B6min are shown in *red* on the structure of hβ~2~m (*gray* schematic) and predominantly involve residues in the A, B, E, and D β-strands of hβ~2~m. By contrast, the C, F, and G β-strands show relatively little change in intensity (*bottom*). *B*, surface representation of hβ~2~m highlighting the interface residues (*red*). *C*, the 2′F B6min-hβ~2~m binding interface involves seven aromatic residues (*light green*), seven positively charged residues (*blue*), and seven negatively charged residues (*pink*).](zbc0421496570008){#F8}

#### 2′F B6min Alters the Co-assembly of ΔN6 and hβ~2~m

The NMR and fluorescence data presented above indicate that 2′F B6min binds tightly to hβ~2~m, but only weakly and non-specifically to ΔN6. At pH 6.2 hβ~2~m does not self-assemble into amyloid fibrils *in vitro* over a time scale of several weeks at a concentration of 40 μ[m]{.smallcaps}, even using significant agitation ([@B13], [@B49], [@B50]). In contrast, ΔN6 rapidly and quantitatively forms fibrils under these conditions ([@B19], [@B49]). When the two proteins are incubated together at this pH, they co-polymerize, forming hetero-polymeric fibrils with distinct structural properties compared with either of their homo-polymeric counterparts ([@B4]). To determine whether 2′F B6min is able to affect the co-aggregation of hβ~2~m and ΔN6 (due to preferential binding of the aptamer to one of the fibrillating monomers), the two proteins were mixed (each at a concentration of 40 μ[m]{.smallcaps}) in the presence or absence of a 2-fold molar excess of 2′F B6min (160 μ[m]{.smallcaps}) at pH 6.2. Assembly was monitored by separating soluble and insoluble material by centrifugation and subsequent analysis of each fraction by SDS-PAGE (see "Experimental Procedures") ([Fig. 9](#F9){ref-type="fig"}). In parallel, a sample of the assembly products were monitored using transmission EM (TEM) to confirm whether amyloid fibrils were produced. The results of these experiments showed that in the absence of 2′F B6min, each protein remains in the soluble fraction up to the 24-h time point, after which time insoluble material containing both proteins forms ([Fig. 9](#F9){ref-type="fig"}*A*). After 166 h of incubation, both proteins are also found in the pellet presumably due to their co-polymerization into fibrils ([@B4]). By contrast, in the presence of 2′F B6min aggregation occurs more rapidly, with \>90% of ΔN6 and ∼40% of hβ~2~m forming fibrillar material after 24 h. TEM images of the samples after 166 h confirmed that the insoluble material in the pellets contains amyloid fibrils ([Fig. 9](#F9){ref-type="fig"}, *A* and *B*), although the precise location of each protein within each fibril (*i.e.* the extent to which co-polymerization occurred) could not be ascertained from these experiments. Presumably, the interaction between soluble ΔN6 and hβ~2~m is inhibited by 2′F B6min, leading to rapid polymerization of ΔN6, which in part co-polymerizes with hβ~2~m.

![**2′F B6min affects hβ~2~m-ΔN6 co-polymerization into fibrils.** *A*, the course of aggregation of mixtures of hβ~2~m and ΔN6 (each 40 μ[m]{.smallcaps}) in the absence of a 2-molar excess of aptamer determined by SDS-PAGE. The morphology of the aggregates formed after 166 h is shown by TEM. *B*, as described for *A* but in the presence of a 2-fold molar excess of 2′F B6min. *S*, supernatant; *P*, pellet. Incubation was performed in 50 m[m]{.smallcaps} MES, 120 m[m]{.smallcaps} NaCl, pH 6.2, with 600 rpm agitation at 37 °C. The *scale bars* on the TEM images represent 500 nm. For the *inset*, *scale bars* in the TEM images are 200 nm.](zbc0421496570009){#F9}

DISCUSSION
==========

To derive a structural mechanism of amyloid formation, the identity and structure of all assembling components must be defined, and how these species interact and form the cross-β-structure of amyloid should be determined. Here, RNA SELEX has been used to generate a specific, high-affinity aptamer (2′F B6) against monomeric hβ~2~m. Importantly, despite only subtle differences in the structures of monomeric hβ~2~m and its N-terminal truncation variant ΔN6 at pH 6.2 ([Fig. 1](#F1){ref-type="fig"}, *A* and *B*), 2′F B6 is able to discriminate between these structures, showing tight and highly specific binding to the β-sheet containing the A, B, E, and D strands of hβ~2~m. By contrast, weak, nonspecific binding is observed to ΔN6 that is detectable only at the high protein and RNA concentrations used for NMR (60 μ[m]{.smallcaps} protein). The discrimination between hβ~2~m and ΔN6 by 2′F B6 can be explained, at least in part, by the presence of Lys-6 in the binding interface. However, given that the binding interface appears to involve an extended region spanning the A, B, E, and D β-strands, other residues must also contribute to affinity. Indeed, differences in the organization of residues on the surfaces of hβ~2~m and ΔN6 that result from the isomerization of the X-Pro-32 peptide bond from the native *cis* isomer in hβ~2~m to the *trans* isomer in ΔN6 ([@B19]), and/or the decreased stability ([@B13]) and increased conformational dynamics of ΔN6 compared with hβ~2~m ([@B19]), may also contribute to 2′F B6 discriminating between these otherwise similar structures. For example, although the structure of the backbone is highly conserved between hβ~2~m and ΔN6 ([Fig. 1](#F1){ref-type="fig"}*B*), the orientation of the side chains of aromatic residues involved in the aptamer binding interface differs significantly ([Fig. 10](#F10){ref-type="fig"}*A*). Furthermore, the organization of hydrophobic and charged residues on the surface formed by the A, B, E, and D β-strands in hβ~2~m differs significantly from ΔN6 ([Fig. 10](#F10){ref-type="fig"}*B*). Accordingly, the apical region of this surface in hβ~2~m is more highly positively charged than its equivalent in ΔN6 (this region contains the N-terminal six amino acids, including Lys-6) ([Fig. 10](#F10){ref-type="fig"}*B*). In addition, the organization of negatively charged residues (involving the AB loop, the EF loop, and the C terminus) also differs between the two proteins ([Fig. 10](#F10){ref-type="fig"}*B*). In total, therefore, the balance between electrostatic and hydrophobic residues, crucial for nucleic acid binding ([@B51]), is distinct in hβ~2~m and ΔΝ6, partly due to the removal of the N-terminal six amino acids, and due in part to differences in solvent exposure of hydrophobic residues in the DE and BC loops in the two proteins that occur as a consequence of X-Pro-32 isomerization.

![**Structural differences between hβ~2~m and ΔΝ6 in the aptamer binding surface.** *A*, the aromatic residues located in the interface between 2′F B6min and hβ~2~m (see [Fig. 8](#F8){ref-type="fig"}) are highlighted as sticks on hβ~2~m (*black ribbon*) and ΔΝ6 (*red ribbon*). Close ups of four residues are shown alongside. *B*, the structure of hβ~2~m (*left*) and ΔΝ6 (*right*) shown as a surface representation colored by its electrostatic potential (*blue*, positive; *red*, negative). The N-terminal region is highlighted in a *circle*, and the DE loop region is annotated with a *black arc*.](zbc0421496570010){#F10}

The role of ΔN6 in DRA is not currently understood. Although ΔN6 is present in the amyloid deposits found in patients with DRA ([@B52]), it remains unknown whether the N-terminal truncation of hβ~2~m occurs pre- or post-fibril formation. Additionally, the interaction between hβ~2~m and ΔN6 *in vitro* is complex, with ΔN6 possessing the ability to convert monomeric hβ~2~m into an amyloidogenic conformation ([@B4], [@B19], [@B53]) and to act as a fibrillar seed able to be elongated with hβ~2~m monomers ([@B19], [@B49]). The aptamer selected here may be useful as an analytical probe to derive greater clarity in understanding the early stages of hβ~2~m and ΔN6 co-assembly into amyloid. Given the complexity of amyloid formation, where self-assembly can be initiated by one or more rare conformers that may differ subtly in structure, and that different oligomeric species may exhibit profoundly different cytotoxicity ([@B54], [@B55]), RNA aptamers offer unique potentials as reagents for the analysis of, and interference with, amyloid formation.

The specific and tight binding of 2′F B6 to hβ~2~m alters the course of amyloid assembly in mixtures of hβ~2~m and ΔN6 at pH 6.2. Thus, aptamer binding to hβ~2~m disfavors the incorporation of hβ~2~m into amyloid fibrils during co-assembly with ΔN6 and results in more rapid fibril formation. In the presence of the aptamer, hβ~2~m molecules will become incorporated into fibrils only after aptamer dissociation, possibly by cross-seeding with preformed ΔN6 fibrils ([@B4], [@B49]). Alternatively, ΔN6 may promote conversion of hβ~2~m to an amyloidogenic conformation once 2′F B6min dissociates ([@B4], [@B19], [@B53]), pulling the equilibrium toward co-assembly into fibrils. Given that amyloid formation is under kinetic control, the development of aptamers able to bind their targets with slow off-rates (even for the same apparent *K~d~*) would provide an effective strategy to control assembly. Such aptamers could be isolated by increasing the length of time of the elution steps in SELEX as stringency is increased. Alternatively, coupling of the RNA aptamer to a molecule with known affinity to the target could provide a route to achieving this goal by exploiting avidity effects. Doxycycline, a small molecule tetracycline analog, has been shown to modulate the formation of hβ~2~m fibrils *in vitro* ([@B56]), to reduce articular pain and improve movement in DRA patients ([@B57]), and to correct a locomotory defect in *Caenorhabditis elegans* expressing hβ~2~m ([@B58]). Analysis of the hβ~2~m-doxycycline complex using NMR suggests that the highest affinity binding site (IC~50~ ∼ 50 μ[m]{.smallcaps} ([@B56])) involves residues that lie in the C-terminal region of strand A, the N-terminal region of strand B, and the central residues of the AB loop ([@B56]). A second, lower affinity binding site involves the N-terminal region and residues in the BC and DE loops. An intriguing possibility, therefore, would be to create an aptamer linked to doxycycline such that the relatively tight and specific binding of 2′F B6 can be exploited to enhance binding of doxycycline to its target interface. Creation of such bipartite molecules has been shown to be a highly effective strategy, not just for enhancing the effectiveness of RNA aptamers as delivery vehicles ([@B59][@B60][@B61]), but in many other applications ([@B62][@B63][@B64]).

In conclusion, the biophysical and biochemical studies presented here demonstrate that RNA aptamers can be highly specific and discriminatory probes, modulating co-polymerization reactions and controlling the course of amyloid assembly. How the 2′F B6-hβ~2~m complex changes as fibril formation proceeds and the effect of the aptamer on hetero-polymorphic fibril structure and stability will require further studies, for example, by exploiting the powers of solid-state NMR to analyze fibril structures ([@B65], [@B66]). Further characterization and modification of 2′F B6 will potentially allow the affinity of the aptamer for hβ~2~m to be increased, and selection of aptamers specific for ΔN6 will also allow detailed biophysical analysis of the role of ΔN6 in hβ~2~m-ΔN6 co-polymerization. Understanding this process further may shed light on the molecular mechanisms of fibril formation and how the protein precursors of hetero-polymeric assemblies can be modulated to tailor the extent, rate, and structure of amyloid fibrils.
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